See also this year's filing and all EDGAR filings for this company.
PDF Report 0001821323_2023_Sigilon_Therapeutics_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001821323')"} |
Graph
Absolute values for 0001821323, Sigilon Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 74,411,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,854,000 |
| 3 | remainder_Assets | 10,013,000 |
| 4 | LiabilitiesCurrent | 30,994,000 |
| 5 | LiabilitiesNoncurrent | 17,142,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,979,000 |
| 9 | ResearchAndDevelopmentExpense | 37,631,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 12,944,000 |
| 12 | remainder_NetIncome | 105,000 |
| 13 | remainder_ComprehensiveNetIncome | -419,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 87,278,000 |
| 1 | Liabilities | 48,136,000 |
| 2 | Expenses | 56,610,000 |
| 3 | Revenues | 12,944,000 |
| 4 | StockholdersEquity | 39,142,000 |
| 5 | NetIncome | -43,561,000 |
| 6 | ComprehensiveNetIncome | -43,770,500 |
| 7 | BaseVar | 102,746,000 |
| 8 | EconomicCapitalRatio | 0.348 |
Edgar->Model Mapping
Feature Distribution
Change over Time
